Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes.

Tuesday, August 01, 2000 @ 8:37:00 AM - Written by Cardiovasc Res. 2000 Aug 18;47(3):549-55.

Hung LM, Chen JK, Huang SS, Lee RS, Su MJ.

Institute of Pharmacology, College of Medicine, National Taiwan University, No. 1, Sec. 1, Jen-Ai Road, Taipei, Taiwan.

BACKGROUND: The major objective of the present study was to examine the cardioprotective effect of resveratrol, an antioxidant presents in red wines, in the rat after ischemia and ischemia-reperfusion (I-R). METHODS: The left main coronary artery was occluded for 30 or 5 min followed by a 30-min reperfusion in anesthetized rats. Animals were preinfused with and without resveratrol before occlusion and the severity of ischemia- and I-R-induced arrhythmias and mortality were compared. RESULTS: Resveratrol pretreatment had no effect on ischemia-induced arrhythmias nor on mortality. In contrast, a dramatic protective effects were observed against I-R-induced arrhythmias and mortality. Resveratrol pretreatment both reduced the incidence and duration of ventricular tachycardia (VT) and ventricular fibrillation (VF). During the same period, resveratrol pretreatment also increased nitric oxide (NO) and decreased lactate dehydrogenase levels in the carotid blood. CONCLUSIONS: Resveratrol is a potent antiarrhythmic agent with cardioprotective properties in I-R rats. The cardioprotective effects of resveratrol in the I-R rats may be correlated with its antioxidant activity and upregulation of NO production.

PMID: 10963727

Leave a Comment
Your Name:
Your Email Address:
(will not be shown)
Your Comments:
Enter the code exactly as you see it in the image:
Code Image - Please contact webmaster if you have problems seeing this image code Load New Code

Copyright 2017 Advanced Life Research